Development and evaluation of ActSeq: A targeted next-generation sequencing panel for clinical oncology use.

We developed a NGS panel with a focus on clinically actionable gene mutations and validated the performance in library construction, sequencing and variant calling. High concordance with reference materials and orthogonal mutation detection was observed.